Jupiter Neurosciences Files Q3 10-Q
Ticker: JUNS · Form: 10-Q · Filed: 2024-12-23T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
JUPITER NEUROSCIENCES Q3 10-Q FILED. FINANCIALS UPDATED.
AI Summary
Jupiter Neurosciences, Inc. filed its Q3 10-Q report on December 23, 2024, for the period ending September 30, 2024. The company, formerly Jupiter Orphan Therapeutics, Inc., is incorporated in Delaware and operates in the pharmaceutical preparations sector. Key financial data and changes in equity accounts are detailed within the filing.
Why It Matters
This filing provides investors with an update on Jupiter Neurosciences' financial performance and position as of the end of the third quarter of 2024.
Risk Assessment
Risk Level: low — The filing is a routine quarterly report and does not contain immediate, significant negative news.
Key Players & Entities
- JUPITER NEUROSCIENCES, INC. (company) — Filer
- Jupiter Orphan Therapeutics, Inc. (company) — Former company name
- 20240930 (date) — Reporting period end date
- 20241223 (date) — Filing date
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is September 30, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on December 23, 2024.
What was Jupiter Neurosciences, Inc. formerly known as?
Jupiter Neurosciences, Inc. was formerly known as Jupiter Orphan Therapeutics, Inc.
In which state is Jupiter Neurosciences, Inc. incorporated?
Jupiter Neurosciences, Inc. is incorporated in Delaware (DE).
What is the Standard Industrial Classification code for Jupiter Neurosciences, Inc.?
The Standard Industrial Classification code for Jupiter Neurosciences, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
From the Filing
0001493152-24-051847.txt : 20241223 0001493152-24-051847.hdr.sgml : 20241223 20241223164640 ACCESSION NUMBER: 0001493152-24-051847 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 59 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241223 DATE AS OF CHANGE: 20241223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JUPITER NEUROSCIENCES, INC. CENTRAL INDEX KEY: 0001679628 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 474828381 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41265 FILM NUMBER: 241574486 BUSINESS ADDRESS: STREET 1: 1001 NORTH US HWY 1 STREET 2: SUITE 504 CITY: JUPITER STATE: FL ZIP: 33477 BUSINESS PHONE: (561) 406-6154 MAIL ADDRESS: STREET 1: 1001 NORTH US HWY 1 STREET 2: SUITE 504 CITY: JUPITER STATE: FL ZIP: 33477 FORMER COMPANY: FORMER CONFORMED NAME: Jupiter Orphan Therapeutics, Inc. DATE OF NAME CHANGE: 20160713 10-Q 1 form10-q.htm false Q3 --12-31 0001679628 0001679628 2024-01-01 2024-09-30 0001679628 2024-12-23 0001679628 2024-09-30 0001679628 2023-12-31 0001679628 us-gaap:NonrelatedPartyMember 2024-09-30 0001679628 us-gaap:NonrelatedPartyMember 2023-12-31 0001679628 us-gaap:RelatedPartyMember 2024-09-30 0001679628 us-gaap:RelatedPartyMember 2023-12-31 0001679628 us-gaap:SeriesAPreferredStockMember 2024-09-30 0001679628 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001679628 2024-07-01 2024-09-30 0001679628 2023-07-01 2023-09-30 0001679628 2023-01-01 2023-09-30 0001679628 us-gaap:CommonStockMember 2023-12-31 0001679628 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001679628 JUNS:ReceivablesForSaleOfStockMember 2023-12-31 0001679628 us-gaap:RetainedEarningsMember 2023-12-31 0001679628 us-gaap:CommonStockMember 2024-03-31 0001679628 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001679628 JUNS:ReceivablesForSaleOfStockMember 2024-03-31 0001679628 us-gaap:RetainedEarningsMember 2024-03-31 0001679628 2024-03-31 0001679628 us-gaap:CommonStockMember 2024-06-30 0001679628 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001679628 JUNS:ReceivablesForSaleOfStockMember 2024-06-30 0001679628 us-gaap:RetainedEarningsMember 2024-06-30 0001679628 2024-06-30 0001679628 us-gaap:CommonStockMember 2022-12-31 0001679628 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001679628 us-gaap:RetainedEarningsMember 2022-12-31 0001679628 2022-12-31 0001679628 us-gaap:CommonStockMember 2023-03-31 0001679628 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001679628 us-gaap:RetainedEarningsMember 2023-03-31 0001679628 2023-03-31 0001679628 us-gaap:CommonStockMember 2023-06-30 0001679628 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001679628 us-gaap:RetainedEarningsMember 2023-06-30 0001679628 2023-06-30 0001679628 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001679628 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001679628 JUNS:ReceivablesForSaleOfStockMember 2024-01-01 2024-03-31 0001679628 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001679628 2024-01-01 2024-03-31 0001679628 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001679628 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001679628 JUNS:ReceivablesForSaleOfStockMember 2024-04-01 2024-06-30 0001679628 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001679628 2024-04-01 2024-06-30 0001679628 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001679628 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001679628 JUNS:ReceivablesForSaleOfStockMember 2024-07-01 2024-09-30 0001679628 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001679628 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001679628 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001679628 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001679628 2023-01-01 2023-03-31 0001679628 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001679628 us-gaap:AdditionalPaidInCapital